Mirae Asset Global ETFs Holdings’s AbbVie ABBV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.8M	Buy	198,239 +10,396	+6%	+$2.31M	0.06%	284
2025 Q4	$42.9M	Sell	187,843 -154,171	-45%	-$35.1M	0.06%	279
2025 Q3	$79.1M	Buy	342,014 +122,659	+56%	+$25M	0.13%	166
2025 Q2	$40.7M	Sell	219,355 -120,450	-35%	-$22.4M	0.08%	246
2025 Q1	$71.2M	Buy	339,805 +54,966	+19%	+$10.7M	0.15%	147
2024 Q4	$50.6M	Sell	284,839 -39,933	-12%	-$7.34M	0.11%	206
2024 Q3	$64.1M	Buy	324,772 +45,481	+16%	+$8.49M	0.14%	150
2024 Q2	$47.9M	Buy	+279,291	New	+$46.3M	0.11%	181

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ABBV Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its AbbVie (ABBV) stake by 5.5% in Q1 2026, buying an estimated $2.31M and bringing the position to 198,239 shares worth $42.8M. The position accounts for 0.06% of the portfolio, ranked #284.

Mirae Asset Global ETFs Holdings first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $79.1M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mirae Asset Global ETFs Holdings held 198,239 shares of AbbVie worth $42.8M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 10,396 AbbVie shares in Q1 2026, an estimated $2.31M.
AbbVie made up 0.06% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #284 holding.
Mirae Asset Global ETFs Holdings first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's AbbVie position peaked at $79.1M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.